Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107683.htm |
| EX-32.2 - EXHIBIT 32.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107685.htm |
| EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107684.htm |
| EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107682.htm |
| EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107681.htm |
| EX-23.2 - EXHIBIT 23.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107680.htm |
| EX-23.1 - EXHIBIT 23.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107679.htm |
| 10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | navb20171231_10k.htm |
Exhibit 21.1
Subsidiaries of Navidea Biopharmaceuticals, Inc.
|
Subsidiaries |
Jurisdiction of Incorporation |
Percentage Owned by Registrant |
|
|
Navidea Biopharmaceuticals Limited |
United Kingdom |
100% |
|
|
Macrophage Therapeutics, Inc. |
Delaware, United States |
99.9% |
|